The U.S. is currently experiencing a shortage of Becton Dickinson BACTEC blood culture media bottles. This shortage has the potential to disrupt patient care by leading to delays in diagnosis, misdiagnosis or other challenges in patients with certain infectious diseases, in addition to impacts on follow-up patient care and antimicrobial stewardship efforts. Related resources for health care providers, labs, facilities and health departments are provided below and will be updated if additional information becomes available.
The Food and Drug Administration Office of Supply Chain Resilience is responsible for managing activities to anticipate and prevent disruptions to the supply chain for medical devices. If you are experiencing a significant shortage of BD BACTEC blood culture bottles, please contact FDA at deviceshortages@fda.hhs.gov.
Resources
- Centers for Disease Control and Prevention
- Disruptions in Availability of Becton Dickinson (BD) BACTEC Blood Culture Bottles Blood Culture Bottles (CDC HAN Advisory, July 23, 2024)
- Blood Culture Contamination: An Overview for Infection Control and Antibiotic Stewardship Programs Working With the Clinical Laboratory
- Preventing Adult Blood Culture Contamination: A Quality Tool for Clinical Laboratory Professionals
- Diagnostic Excellence: A New Quality Tool to Prevent Blood Culture Contamination
- Food and Drug Administration
- Becton Dickinson
Additional Resources for Clinical Decision Making
- Does This Patient Need Blood Cultures? A Scoping Review of Indications for Blood Cultures in Adult Nonneutropenic Inpatients (Clinical Infectious Diseases)
- Consensus Recommendations for Blood Culture Use in Critically Ill Children Using a Modified Delphi Approach (Pediatric Critical Care Medicine)